Dermatology News

In this video, Brian S. Kim, MD, discusses the management of patients with severe chronic spontaneous urticaria.

In this video, Brian S. Kim, MD, discusses quality-of-life considerations for patients with chronic spontaneous urticaria.

In this video, Brian S. Kim, MD, discusses the importance of monitoring patients after initiating treatment for chronic spontaneous urticaria.

In this video, Brian S. Kim, MD, discusses treatment options in chronic spontaneous urticaria.

DENVER — Povorcitinib, an oral JAK-1 inhibitor currently being investigated for hidradenitis suppurativa, demonstrated substantial clinical efficacy through 54 weeks, according to new data.

Physicians spend a decade mastering the science of medicine yet receive almost no formal training in personal finance.

DENVER — Litifilimab was superior to placebo for reducing skin disease activity in cutaneous lupus erythematosus, according to phase 2 data presented at the American Academy of Dermatology Annual Meeting.

DENVER — Adults with moderate to severe hidradenitis suppurativa experienced substantial long-term symptom relief and quality of life improvements with the investigational nanobody inhibitor sonelokimab, according to a speaker.

DENVER — Once-daily oral zasocitinib for moderate to severe plaque psoriasis demonstrated rapid and durable skin clearance and a consistent safety profile, according to data presented at the American Academy of Dermatology Annual Meeting.

DENVER — Adults with active psoriatic arthritis and obesity had improvements in disease activity, physical function, weight loss and quality of life with combination ixekizumab plus tirzepatide, according to phase 3 study results.